Cardiometabolic Syndrome: Clinical Trials

1 recruiting. 1 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	1	Recruiting 1

Follow Cardiometabolic Syndrome: new trials by email Literature Review of Cardiometabolic Syndrome trials Research Report on Cardiometabolic Syndrome

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL - Drug Interactions, Primary Prevention	Phase 4	Recruiting	University of California, San Diego	100	2025-04-02	2026-07-13

Narrower conditions

Metabolic Syndrome (1)

Broader conditions

Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Insulin Resistance (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

ALN-PCS (1)

Sponsors

University of California, San Diego (1)

Countries

United States (1)

Top investigators

Antoinette Birs, MD (1)  ·  Eric D Adler, MD (1)  ·  Michael Wilkinson, MD (1)  ·  Pam Taub, MD (1)